NCT05571215

Brief Summary

Recent literature has shown that individuals with persistent chronic pain often exhibit altered cognitive, affective, and sensorimotor behaviors despite a full recovery of peripheral structural injury. Clinically this can be observed via altered pain behaviors (e.g., pain catastrophizing and kinesiophobia) and increased sensitivity to pressure stimuli, each of which are predictive of poorer outcomes. These alterations are believed to have arisen from maladaptive reorganization of brain networks, including cognitive-evaluative and affective networks. Structurally, decreased gray matter in the dorsolateral prefrontal cortex (DLFPC), a key area in the cognitive-affective processing of pain, has been found in those suffering from chronic musculoskeletal pain. The changes are shown to be reversible when the pain is successfully treated and uniquely connected to cognitive-affective behaviors in that as catastrophizing or fear decreases, DLPFC density increases. Pain science education (PNE), a cognitive-behavioral intervention, has shown promising effects, especially on cognitive- affective behaviors. Non-invasive brain stimulation, such as transcranial direct current stimulation (tDCS), has also been shown to reduce pain and pain-associated behavioral changes in chronic pain. However, the combined effects of these two interventions have not been investigated. It remains unclear if priming the cognitive-affective circuitry that is conceptualized to support PNE with tDCS will augment the behavioral effect of PNE. Therefore, the primary objective of this pilot study is to examine the effects of combining PNE and tDCS on pain catastrophizing, kinesiophobia, and hypersensitivity to pressure stimuli in patients with chronic low back pain (CLBP). We will also examine the influence of PNE and tDCS on cortical network patterns in a subgroup of participants. The results of this pilot study could support the use of tDCS as a priming agent to increase the effect of cognitive-behavioral interventions such as PNE. With success, this intervention could be safely and easily replicated in the clinical setting and provide a novel approach to treating chronic pain more effectively. In addition, the outcomes can further the understanding of more precisely matching specific cortical targets with the desired behavioral therapy

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2022

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

August 24, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 7, 2022

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

October 7, 2022

Status Verified

October 1, 2022

Enrollment Period

1.5 years

First QC Date

August 24, 2022

Last Update Submit

October 4, 2022

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change in Pain Catastrophizing Scale

    The 13-item PCS (0-52) will be used to determine each participant's pain catastrophizing level. Pain catastrophizing is characterized by the tendency to magnify pain stimulus and to feel helpless in the presence of pain. A higher score indicates higher pain catastrophizing level.

    Completed prior to first intervention session and immediately following final intervention sessions

  • Change in Tampa Scale of Kinesiophobia

    . The 17-item TSK (17-68) will be used to determine each participant's level of fear of movement. A higher score indicates higher level of kinesiophobia.

    Completed prior to first intervention session and immediately following final intervention sessions

  • Change in Stroop Color Word Test

    The Stroop Color and Word Test (SCWT) will be used to assess participants ability to inhibit cognitive interference. Cognitive interference occurs when the processing of one stimulus influences the ability to process another feature of the same stimulus.

    Completed prior to first intervention session and immediately following final intervention sessions

  • Change in Numeric Pain Rating Scale

    The NPRS (0-10) will be recorded by the participants rating their current pain on the day of assessment, 0 being no pain and 10 being the worst imaginable pain.

    Completed prior to first intervention session and immediately following final intervention sessions

Secondary Outcomes (3)

  • Change in Comprehensive Trail Making

    Completed prior to first intervention session and immediately following final intervention sessions

  • Change in Coding Test

    Completed prior to first intervention session and immediately following final intervention sessions

  • Change in Pressure Pain Thresholds

    Completed prior to first intervention session and immediately following final intervention sessions

Other Outcomes (1)

  • Functional MRI

    Completed with 1-2 weeks prior to intervention protocol and within 1 week of completion of the protocol

Study Arms (1)

Combined tDCS and PNE

EXPERIMENTAL

This is a single-arm pilot study used to evaluate the treatment effects of combining pain neuroscience education (PNE) and transcranial direct current stimulation (tDCS). All participants will receive the same Intervention, which includes five sessions of tDCS to the left dorsolateral prefrontal cortex (DLPFC) plus PNE over two weeks.

Device: Transcranial Direct Current StimulationBehavioral: Pain Neuroscience Education

Interventions

Five sessions of tDCS will be performed following completions of baseline data collection. This will include 3 sessions during week one and 2 sessions in week 2. A tDCS unit (neuroConn Ilmenau, Germany) will be applied to the left DLPFC with participants in the sitting position for a 20 minutes of tDCS. An anodal 2.0 mA current will be applied to each participant, including a 30-second ramp up at the beginning of stimulation and a 30 second ramp down period and the end of stimulation. The left DLPFC (F3 from EEG 10/20 system) will be located using the Beam F3 measurement system. These parameters are consistent with those used in current literature on tDCS for pain. tDCS procedures will be performed by the PI (CA).

Combined tDCS and PNE

Immediately following completion of each tDCS intervention, participants will be given a one-on-one PNE session provided also by the PT (CA), who is a licensed healthcare provider with expertise in delivery of the content. This educational session will last about 30 minutes. Initial sessions will involve discussion and questioning of participants about their own understanding of their pain and this information will be used to subsequently individualize the forthcoming educational sessions. The educational sessions will follow the content of Explain Pain, a patient booklet, and will include information on the neurophysiology of pain, pain as typical process, the transition from acute to chronic pain, neuroplasticity, central sensitization, factors that promote pain chronicity. Information will be presented verbally along with visuals on paper.

Combined tDCS and PNE

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Reports chronic low back pain defined as a back pain problem that has persisted at least 3 months and has resulted in pain on at least half the days in the past 6 months
  • Age: 18-65 years
  • Score \>30 on Pain Catastrophizing Scale

You may not qualify if:

  • History of previous lower back surgery
  • Systemic joint disease (e.g. rheumatoid arthritis)
  • Evidence of red flags (e.g. fracture, infection, tumor, cauda equina syndrome)
  • Cancer
  • Neurological disorders
  • Neuropathy
  • Raynaud's disease
  • Pregnancy
  • An inability to maintain the testing and treatment positions (i.e. sitting for \>30 minutes).
  • A history of significant head trauma
  • An electrical, magnetic, or mechanical implantation (e.g. cardiac pacemakers or intracerebral vascular
  • clip)
  • A metal implant in the head or neck areas
  • A history of seizures or unexplained loss of consciousness
  • An immediate family member with epilepsy
  • +3 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

High Point University

High Point, North Carolina, 27268, United States

RECRUITING

Related Publications (1)

  • Alcon C, Zoch C, Luetkenhaus R, Lyman E, Brizzolara K, Goh HT, Wang-Price S. Combined transcranial direct current stimulation and pain neuroscience education for chronic low back pain: a randomized controlled trial. Pain Med. 2025 Feb 1;26(2):90-97. doi: 10.1093/pm/pnae101.

MeSH Terms

Conditions

Kinesiophobia

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Phobic DisordersAnxiety DisordersMental Disorders

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Central Study Contacts

Cory A Alcon, DPT

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Pilot study - intervention group only
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 24, 2022

First Posted

October 7, 2022

Study Start

July 1, 2022

Primary Completion

December 31, 2023

Study Completion

December 31, 2023

Last Updated

October 7, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will not share

Locations